Milestone Scientific Inc. (MLSS)

Market Cap	26.37M -11.8%
Revenue (ttm)	9.42M +3.7%
Net Income	-4.14M
EPS	-0.05
Shares Out	88.74M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	92,917
Open	0.2919
Previous Close	0.3097
Day's Range	0.2850 - 0.3156
52-Week Range	0.2181 - 0.5796
Beta	1.16
Analysts	Buy
Price Target	1.25 (+320.59%)
Earnings Date	Nov 12, 2026

About MLSS

Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides The Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery sys...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Nov 3, 1995
• Employees: 15
• Stock Exchange: NYSE American
• Ticker Symbol: MLSS
• Website: https://www.milestonescientific.com

Financial Performance

In 2025, Milestone Scientific's revenue was $8.97 million, an increase of 3.99% compared to the previous year's $8.63 million. Losses were -$5.72 million, 21.4% more than in 2024.

Analyst Summary

According to 2 analysts, the average rating for MLSS stock is "Buy." The 12-month stock price target is $1.25, which is an increase of 320.59% from the latest price.

Price Target

$1.25

(320.59% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Nov 12, 2026

Data Sources Report a data error